| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrine Care |
Laboratory and Clinic of Experimental Medicine and Endocrinology (A.V.d.B., R.B.), Departments of Nuclear Medicine (A.M., T.D.P., L.M.), Pathology (M.D., B.V.D.), and Head and Neck Surgery (P.D.), Universitaire Ziekenhuizen Gasthuisberg, B-3000 Leuven, Belgium
Address all correspondence and requests for reprints to: R. Bouillon, Laboratory for Experimental Medicine and Endocrinology, University Hospital Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium. E-mail: . roger.bouillon{at}med.kuleuven.ac.be
Abstract
Fluorodeoxyglucose (FDG) whole body positron emission tomography (PET) scan is increasingly used in the diagnostic work-up or follow-up of patients. In these conditions, positive PET scans with unexpected hot spots within the thyroid region could be defined as thyroid FDG-PET incidentaloma (in analogy with unexpected sonographic thyroid nodules).
We describe eight consecutive patients referred to the endocrine department because of thyroid "hot spots," incidentally detected by whole body FDG-PET scan (September 1999 to March 2001). Using ultrasound, fine needle aspiration cytology (FNAC), and histology reports, we tried to identify the pathology underlying thyroid FDG-PET incidentaloma. FNAC showed an indication for surgery in all patients. Surgery has been performed in 7 patients. Malignancy was correctly identified in five patients: two medullary thyroid carcinomas, one with lymph node invasion, and three papillary thyroid carcinomas with invasion through the thyroid capsule in two of the PTC cases. In two patients with a positive FDG-PET scan, FNAC pointed to follicular neoplasms, and final histology reports showed follicular adenoma. In the remaining patient, FNAC revealed a follicular lesion, but surgery has not yet been performed.
In conclusion, a small series of consecutive thyroid FDG-PET incidentaloma cases is presented and suggests a high rate of clinically relevant malignancies.
This article has been cited by other articles:
![]() |
J. Y. Kwak, E.-K. Kim, M. Yun, A. Cho, M. J. Kim, E. J. Son, and K. K. Oh Thyroid Incidentalomas Identified by 18F-FDG PET: Sonographic Correlation Am. J. Roentgenol., August 1, 2008; 191(2): 598 - 603. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S Al-Zahrani, M.-E. M Abouzied, S. A. Salam, G. Mohamed, A. Rifai, A. Al Sugair, and T. Amin The role of F-18-fluorodeoxyglucose positron emission tomography in the postoperative evaluation of differentiated thyroid cancer Eur. J. Endocrinol., May 1, 2008; 158(5): 683 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Abouzied, E. S. Crawford, and H. A. Nabi 18F-FDG Imaging: Pitfalls and Artifacts J. Nucl. Med. Technol., September 1, 2005; 33(3): 145 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Yi, E. M. Marom, R. F. Munden, M. T. Truong, H. A. Macapinlac, G. W. Gladish, B. S. Sabloff, and D. A. Podoloff Focal Uptake of Fluorodeoxyglucose by the Thyroid in Patients Undergoing Initial Disease Staging with Combined PET/CT for Non-Small Cell Lung Cancer Radiology, July 1, 2005; 236(1): 271 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Pandit-Taskar, H. Schoder, M. Gonen, S. M. Larson, and H. W. D. Yeung Clinical Significance of Unexplained Abnormal Focal FDG Uptake in the Abdomen During Whole-Body PET Am. J. Roentgenol., October 1, 2004; 183(4): 1143 - 1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pacak, G. Eisenhofer, and D. S. Goldstein Functional Imaging of Endocrine Tumors: Role of Positron Emission Tomography Endocr. Rev., August 1, 2004; 25(4): 568 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Agress Jr and B. Z. Cooper Detection of Clinically Unexpected Malignant and Premalignant Tumors with Whole-Body FDG PET: Histopathologic Comparison Radiology, February 1, 2004; 230(2): 417 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Kang, S.-K. Kim, H.-S. Kang, E. S. Lee, J. S. Sim, I. G. Lee, S.-Y. Jeong, and S. W. Kim Prevalence and Risk of Cancer of Focal Thyroid Incidentaloma Identified by 18F-Fluorodeoxyglucose Positron Emission Tomography for Metastasis Evaluation and Cancer Screening in Healthy Subjects J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4100 - 4104. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |